International Congress of the International Liver Transplantation Society (ILTS)

Safety of living ILTS-iLDLT liver donors: Short-term and long-term results

 

For children and adults with liver failure and end-stage liver disease, living donor liver transplantation (LDLT) is a proven treatment option, with lower waiting list mortality and morbidity, and equivalent or better allograft and patient survival than deceased donor liver transplantation. 

 

Currently, there is a lack of detailed data demonstrating long-term outcomes and overall safety, particularly in the population of ‘healthy’ living liver donors. 

 

There is a need to bring together experts involved in the preparation, selection, surgery and follow-up of living donors. They should review, discuss and reach agreement on safe living donor surgery practices and the short- and long-term consequences for living donors. 

 

The consensus is made up of a select group of highly qualified healthcare professionals (including surgeons, hepatologists, radiologists, anaesthetists, scientists, nurses and patient advocates).

 

For more information, please follow the link.